The role of peroxisome proliferator-activated receptor β/δ on the inflammatory basis of metabolic disease

PPAR Research

Volumn , Issue , 2010, Pages

  Vázquez Carrera, Manuel ^a   Coll, Teresa ^a   Barroso, Emma ^a   Lvarez Guardia, David ^a   Serrano, Lucía ^a   Salvad, Laia ^a   Merlos, Manuel ^a   Palomer, Xavier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ADIPOSE TISSUE CELL; ATHEROSCLEROSIS; CELL METABOLISM; HEART FUNCTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC DISORDER; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE;

EID: 77956824021     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/368467     Document Type: Review

References (112)

1. Plutzky J., Expansion and contraction: the mighty, mighty fatty acid Nature Medicine 2009 15 6 618 619
2. Kersten S., Desvergne B., Wahli W., Roles of PPARS in health and disease Nature 2000 405 6785 421 424
3. Castrillo A., Tontonoz P., Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation Annual Review of Cell and Developmental Biology 2004 20 455 480
4. Chinetti G., Fruchart J.-C., Staels B., Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflammation Research 2000 49 10 497 505
5. Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions Progress in Lipid Research 2006 45 2 120 159
6. Zamir I., Zhang J., Lazar M. A., Stoichiometric and steric principles governing repression by nuclear hormone receptors Genes and Development 1997 11 7 835 846
7. Daynes R. A., Jones D. C., Emerging roles of PPARs in inflammation and immunity Nature Reviews Immunology 2002 2 10 748 759
8. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.-C., Heyman R. A., Rose D. W., Glass C. K., Rosenfeld M. G., A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors Cell 1996 85 3 403 414
9. Li M., Pascual G., Glass C. K., Peroxisome proliferator-activated receptor -dependent repression of the inducible nitric oxide synthase gene Molecular and Cellular Biology 2000 20 13 4699 4707
10. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J. M., Gonzalez F. J., Fruchart J.-C., Tedgui A., Haegeman G., Staels B., Peroxisome proliferator-activated receptor negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF- B and AP-1 Journal of Biological Chemistry 1999 274 45 32048 32054
11. Delerive P., Martin-Nizard F., Chinetti G., Trottein F., Fruchart J.-C., Najib J., Duriez P., Staels B., Peroxisome proliferator-activated receptor activators inhibit thrombin- induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway Circulation Research 1999 85 5 394 402
12. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., Derijard B., Desvergne B., Wahli W., Chambon P., Leibowitz M. D., Colombel J.-F., Auwerx J., Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor (PPAR ) heterodimer. A basis for new therapeutic strategies Journal of Experimental Medicine 2001 193 7 827 838
13. Johnson T. E., Holloway M. K., Vogel R., Rutledge S. J., Perkins J. J., Rodan G. A., Schmidt A., Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors Journal of Steroid Biochemistry and Molecular Biology 1997 63 13 1 8
14. Auwerx J., Baulieu E., Beato M., Becker-Andre M., Burbach P. H., Camerino G., Chambon P., Cooney A., Dejean A., Dreyer C., Evans R. M., Gannon F., Giguere V., Gronemeyer H., Gustafsson J.-A., Laudet V., Lazar M. A., Mangelsdorf D. J., Millbrandt J., Milgrom E., Moore D. D., O'Malley B., Parker M., Parker K., Perimann T., Pfahl M., Rosenfeld M. G., Samuels H., Schutz G., Sladek F. M., Stunnenberg H. G., Spedding M., Thummel C., Tsai M.-J., Umesono K., Vennstrom B., Wahli W., Weinberg C., Willson T. M., Yamamoto K., A unified nomenclature system for the nuclear receptor superfamily Cell 1999 97 2 161 163
15. Braissant O., Foufelle F., Scotto C., Daua M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-,-, and- in the adult rat Endocrinology 1996 137 1 354 366
16. Kliewer S. A., Forman B. M., Blumberg B., Ong E. S., Borgmeyer U., Mangelsdorf D. J., Umesono K., Evans R. M., Differential expression and activation of a family of murine peroxisome proliferator-activated receptors Proceedings of the National Academy of Sciences of the United States of America 1994 91 15 7355 7359
17. Barak Y., Liao D., He W., Ong E. S., Nelson M. C., Olefsky J. M., Boland R., Evans R. M., Effects of peroxisome proliferator-activated receptor on placentation, adiposity, and colorectal cancer Proceedings of the National Academy of Sciences of the United States of America 2002 99 1 303 308
18. Peters J. M., Lee S. S. T., Li W., Ward J. M., Gavrilova O., Everett C., Reitman M. L., Hudson L. D., Gonzalez F. J., Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor () Molecular and Cellular Biology 2000 20 14 5119 5128
19. Tan N. S., Michalik L., Noy N., Yasmin R., Pacot C., Heim M., Flhmann B., Desvergne B., Wahli W., Critical roles of PPAR / in keratinocyte response to inflammation Genes and Development 2001 15 24 3263 3277
20. Michalik L., Auwerx J., Berger J. P., Chatterjee V. K., Glass C. K., Gonzalez F. J., Grimaldi P. A., Kadowaki T., Lazar M. A., O'Rahilly S., Palmer C. N. A., Plutzky J., Reddy J. K., Spiegelman B. M., Staels B., Wahli W., International union of pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacological Reviews 2006 58 4 726 741
21. Willson T. M., Lambert M. H., Kliewer S. A., Peroxisome proliferator-activated receptor and metabolic disease Annual Review of Biochemistry 2001 70 341 367
22. Oliver W. R. Jr., Shenk J. L., Snaith M. R., Russell C. S., Plunket K. D., Bodkin N. L., Lewis M. C., Winegar D. A., Sznaidman M. L., Lambert M. H., Xu H. E., Sternbach D. D., Kliewer S. A., Hansen B. C., Willson T. M., A selective peroxisome proliferator-activated receptor agonist promotes reverse cholesterol transport Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5306 5311
23. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W., Control of the peroxisomal -oxidation pathway by a novel family of nuclear hormone receptors Cell 1992 68 5 879 887
24. Takada I., Yu R. T., Xu H. E., Lambert M. H., Montana V. G., Kliewer S. A., Evans R. M., Umesono K., Alteration of a single amino acid in peroxisome proliferator-activated receptor- (PPAR ) generates a PPAR phenotype Molecular Endocrinology 2000 14 5 733 740
25. Xu H. E., Lambert M. H., Montana V. G., Parks D. J., Blanchard S. G., Brown P. J., Sternbach D. D., Lehmann J. M., Wisely G. B., Willson T. M., Kliewer S. A., Milburn M. V., Molecular recognition of fatty acids by peroxisome proliferator-activated receptors Molecular Cell 1999 3 3 397 403
26. Forman B. M., Ruan B., Chen J., Schroepfer G. J. Jr., Evans R. M., The orphan nuclear receptor LXRa is positively and negatively regulated by distinct products of mevalonate metabolism Proceedings of the National Academy of Sciences of the United States of America 1997 94 20 10588 10593
27. Yu K., Bayona W., Kallen C. B., Harding H. P., Ravera C. P., McMahon G., Brown M., Lazar M. A., Differential activation of peroxisome proliferator-activated receptors by eicosanoids Journal of Biological Chemistry 1995 270 41 23975 23983
28. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M. G., Wahli W., Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Molecular Endocrinology 1997 11 6 779 791
29. Shaw N., Elholm M., Noy N., Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor / Journal of Biological Chemistry 2003 278 43 41589 41592
30. Chawla A., Lee C.-H., Barak Y., He W., Rosenfeld J., Liao D., Han J., Kang H., Evans R. M., PPAR is a very low-density lipoprotein sensor in macrophages Proceedings of the National Academy of Sciences of the United States of America 2003 100 3 1268 1273
31. Sznaidman M. L., Haffner C. D., Maloney P. R., Fivush A., Chao E., Goreham D., Sierra M. L., LeGrumelec C., Xu H. E., Montana V. G., Lambert M. H., Willson T. M., Oliver W. R. Jr., Sternbach D. D., Novel selective small molecule agonists for peroxisome proliferator-activated receptor (PPAR )synthesis and biological activity Bioorganic and Medicinal Chemistry Letters 2003 13 9 1517 1521
32. Berger J., Leibowitz M. D., Doebber T. W., Elbrecht A., Zhang B., Zhou G., Biswas C., Cullinan C. A., Hayes N. S., Li Y., Tanen M., Ventre J., Wu M. S., Berger G. D., Mosley R., Marquis R., Santini C., Sahoo S. P., Tolman R. L., Smith R. G., Moller D. E., Novel peroxisome proliferator-activated receptor (PPAR) and PPAR ligands produce distinct biological effects Journal of Biological Chemistry 1999 274 10 6718 6725
33. Shearer B. G., Steger D. J., Way J. M., Stanley T. B., Lobe D. C., Grillot D. A., Iannone M. A., Lazar M. A., Willson T. M., Billin A. N., Identification and characterization of a selective peroxisome proliferator-activated receptor / (NR1C2) antagonist Molecular Endocrinology 2008 22 2 523 529
34. Mathieu P., Lemieux I., Despres J. P., Obesity, inflammation, and cardiovascular risk Clinical Pharmacology and Therapeutics 2010 87 4 407 416
35. Spalding K. L., Arner E., Westermark P. O., Bernard S., Buchholz B. A., Bergmann O., Blomqvist L., Hoffstedt J., Nslund E., Britton T., Concha H., Hassan M., Rydn M., Frisn J., Arner P., Dynamics of fat cell turnover in humans Nature 2008 453 7196 783 787
36. Gustafson B., Gogg S., Hedjazifar S., Jenndahl L., Hammarstedt A., Smith U., Inflammation and impaired adipogenesis in hypertrophic obesity in man American Journal of Physiology 2009 297 5 E999 E1003
37. Roden M., Price T. B., Perseghin G., Petersen K. F., Rothman D. L., Cline G. W., Shulman G. I., Mechanism of free fatty acid-induced insulin resistance in humans Journal of Clinical Investigation 1996 97 2859 2865
38. Boden G., Role of fatty acids in the pathogenesis of insulin resistance and NIDDM Diabetes 1997 46 1 3 10
39. Boden G., Jadali F., White J., Liang Y., Mozzoli M., Chen X., Coleman E., Smith C., Effects of fat on insulin-stimulated carbohydrate metabolism in normal men Journal of Clinical Investigation 1991 88 3 960 966
40. Mathieu P., Pibarot P., Desprs J.-P., Metabolic syndrome: the danger signal in atherosclerosis Vascular Health and Risk Management 2006 2 3 285 302
41. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance Journal of Clinical Investigation 2006 116 11 3015 3025
42. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity Cell 2006 124 4 783 801
43. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance Journal of Clinical Investigation 2006 116 7 1793 1801
44. Nguyen M. T. A., Favelyukis S., Nguyen A.-K., Reichart D., Scott P. A., Jenn A., Liu-Bryan R., Glass C. K., Neels J. G., Olefsky J. M., A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways Journal of Biological Chemistry 2007 282 48 35279 35292
45. Cani P. D., Amar J., Iglesias M. A., Poggi M., Knauf C., Bastelica D., Neyrinck A. M., Fava F., Tuohy K. M., Chabo C., Waget A., Delme E., Cousin B., Sulpice T., Chamontin B., Ferrires J., Tanti J.-F., Gibson G. R., Casteilla L., Delzenne N. M., Alessi M. C., Burcelin R., Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 2007 56 7 1761 1772
46. Rodrguez-Calvo R., Serrano L., Coll T., Moullan N., Snchez R. M., Merlos M., Palomer X., Laguna J. C., Michalik L., Wahli W., Vzquez-Carrera M., Activation of peroxisome proliferator-activated receptor / inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor- B activity via extracellular signal-related kinase 1/2 Diabetes 2008 57 8 2149 2157
47. Chung S., LaPoint K., Martinez K., Kennedy A., Sandberg M. B., McIntosh M. K., Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes Endocrinology 2006 147 11 5340 5351
48. Kang K., Reilly S. M., Karabacak V., Gangl M. R., Fitzgerald K., Hatano B., Lee C.-H., Adipocyte-derived Th2 cytokines and myeloid PPAR regulate macrophage polarization and insulin sensitivity Cell Metabolism 2008 7 6 485 495
49. Lumeng C. N., Deyoung S. M., Saltiel A. R., Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins American Journal of Physiology 2007 292 1 E166 E174
50. Gordon S., Alternative activation of macrophages Nature Reviews Immunology 2003 3 1 23 35
51. Roden M., Perseghin G., Petersen K. F., Hwang J.-H., Cline G. W., Gerow K., Rothman D. L., Shulman G. I., The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans Journal of Clinical Investigation 1996 97 3 642 648
52. Haber E. P., Hirabara S. M., Gomes A. D., Curi R., Carpinelli A. R., Carvalho C. R. O., Palmitate modulates the early steps of insulin signalling pathway in pancreatic islets FEBS Letters 2003 544 13 185 188
53. Hirabara S. M., Silveira L. R., Abdulkader F., Carvalho C. R. O., Procopio J., Curi R., Time-dependent effects of fatty acids on skeletal muscle metabolism Journal of Cellular Physiology 2007 210 1 7 15
54. Silveira L. R., Fiamoncini J., Hirabara S. M., Procpio J., Cambiaghi T. D., Pinheiro C. H. J., Lopes L. R., Curi R., Updating the effects of fatty acids on skeletal muscle Journal of Cellular Physiology 2008 217 1 1 12
55. Schrauwen P., Schrauwen-Hinderling V., Hoeks J., Hesselink M. K. C., Mitochondrial dysfunction and lipotoxicity Biochimica et Biophysica Acta 2009 1801 3 266 271
56. Hirabara S. M., Curi R., Maechler P., Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells Journal of Cellular Physiology 2010 222 1 187 194
57. Wellen K. E., Hotamisligil G. S., Inflammation, stress, and diabetes Journal of Clinical Investigation 2005 115 5 1111 1119
58. Griffin M. E., Marcucci M. J., Cline G. W., Bell K., Barucci N., Lee D., Goodyear L. J., Kraegen E. W., White M. F., Shulman G. I., Free fatty acid-induced insulin resistance is associated with activation of protein kinase C and alterations in the insulin signaling cascade Diabetes 2000 48 6 1270 1274
59. Cortright R. N., Azevedo J. L. Jr., Zhou Q., Sinha M., Pories W. J., Itani S. I., Dohm G. L., Protein kinase C modulates insulin action in human skeletal muscle American Journal of Physiology 2000 278 3 E553 E562
60. Itani S. I., Zhou Q., Pories W. J., MacDonald K. G., Dohm G. L., Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity Diabetes 2000 49 8 1353 1358 (Pubitemid 30624237)
61. Gual P., Le Marchand-Brustel Y., Tanti J.-F., Positive and negative regulation of insulin signaling through IRS-1 phosphorylation Biochimie 2005 87 1 99 109
62. Hotamisligil G. S., Peraldi P., Budavari A., Ellis R., White M. F., Spiegelman B. M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF- -and obesity-induced insulin resistance Science 1996 271 5249 665 668
63. Perseghin G., Petersen K., Shulman G. I., Cellular mechanism of insulin resistance: potential links with inflammation International Journal of Obesity 2003 27 supplement 3 S6 S11
64. Kim J. K., Kim Y.-J., Fillmore J. J., Chen Y., Moore I., Lee J., Yuan M., Li Z. W., Karin M., Perret P., Shoelson S. E., Shulman G. I., Prevention of fat-induced insulin resistance by salicylate Journal of Clinical Investigation 2001 108 3 437 446
65. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.-W., Karin M., Shoelson S. E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk Science 2001 293 5535 1673 1677
66. Pickup J. C., Mattock M. B., Chusney G. D., Burt D., NIDDM as a disease of the innate immune system: association of acute- phase reactants and interleukin-6 with metabolic syndrome X Diabetologia 1997 40 11 1286 1292
67. Kern P. A., Ranganathan S., Li C., Wood L., Ranganathan G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance American Journal of Physiology 2001 280 5 E745 E751
68. Pradhan A. D., Manson J. E., Rifai N., Buring J. E., Ridker P. M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus Journal of the American Medical Association 2001 286 3 327 334
69. Reznick R. M., Shulman G. I., The role of AMP-activated protein kinase in mitochondrial biogenesis Journal of Physiology 2006 574 1 33 39
70. Sebastin D., Herrero L., Serra D., Asins G., Hegardt F. G., CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance American Journal of Physiology 2007 292 3 E677 E686
71. Bruce C. R., Hoy A. J., Turner N., Watt M. J., Allen T. L., Carpenter K., Cooney G. J., Febbraio M. A., Kraegen E. W., Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance Diabetes 2009 58 3 550 558
72. Barish G. D., Narkar V. A., Evans R. M., PPAR : a dagger in the heart of the metabolic syndrome Journal of Clinical Investigation 2006 116 3 590 597
73. Krmer D. K., Al-Khalili L., Guigas B., Leng Y., Garcia-Roves P. M., Krook A., Role of AMP kinase and PPAR in the regulation of lipid and glucose metabolism in human skeletal muscle Journal of Biological Chemistry 2007 282 27 19313 19320
74. Coll T., lvarez-Guardia D., Barroso E., Gmez-Foix A.M., Palomer X., Laguna J. C., Vzquez-Carrera M., Activation of peroxisome proliferator-activated receptor- by GW501516 prevents fatty acid-induced nuclear factor- B activation and insulin resistance in skeletal muscle cells Endocrinology 2010 151 4 1560 1569
75. Risrus U., Sprecher D., Johnson T., Olson E., Hirschberg S., Liu A., Fang Z., Hegde P., Richards D., Sarov-Blat L., Strum J. C., Basu S., Cheeseman J., Fielding B. A., Humphreys S. M., Danoff T., Moore N. R., Murgatroyd P., O'Rahilly S., Sutton P., Willson T., Hassall D., Frayn K. N., Karpe F., Activation of peroxisome proliferator-activated receptor (PPAR) promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men Diabetes 2008 57 2 332 339
76. Sprecher D. L., Massien C., Pearce G., Billin A. N., Perlstein I., Willson T. M., Hassall D. G., Ancellin N., Patterson S. D., Lobe D. C., Johnson T. G., Triglyceride: high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor agonist Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 2 359 365
77. Barger P. M., Brandt J. M., Leone T. C., Weinheimer C. J., Kelly D. P., Deactivation of peroxisome proliferator-activated receptor- during cardiac hypertrophic growth Journal of Clinical Investigation 2000 105 12 1723 1730
78. Allard M. F., Emanuel P. G., Russell J. A., Bishop S. P., Digerness S. B., Anderson P. G., Preischemic glycogen reduction or glycolytic inhibition improves postischemic recovery of hypertrophied rat hearts American Journal of Physiology 1994 267 1 H66 H74
79. Kagaya Y., Kanno Y., Takeyama D., Ishide N., Maruyama Y., Takahashi T., Ido T., Takishima T., Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats: a quantitative autoradiographic study Circulation 1990 81 4 1353 1361
80. Doenst T., Goodwin G. W., Cedars A. M., Wang M., Stepkowski S., Taegtmeyer H., Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro Metabolism: Clinical and Experimental 2001 50 9 1083 1090
81. Planavila A., Laguna J. C., Vzquez-Carrera M., Nuclear factor- B activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy Journal of Biological Chemistry 2005 280 17 17464 17471
82. Planavila A., Laguna J. C., Vzquez-Carrera M., Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor- B activation Biochimica et Biophysica Acta 2005 1687 13 76 83
83. Planavila A., Laguna J. C., Vzquez-Carrera M., Nuclear factor- B activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy Journal of Biological Chemistry 2005 280 17 17464 17471
84. Hirotani S., Otsu K., Nishida K., Higuchi Y., Morita T., Nakayama H., Yamaguchi O., Mano T., Matsumura Y., Ueno H., Tada M., Hori M., Involvement of nuclear factor- B and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy Circulation 2002 105 4 509 515
85. Smeets P. J. H., Teunissen B. E. J., Planavila A., De Vogel-Van Den Bosch H., Willemsen P. H. M., Van Der Vusse G. J., Van Bilsen M., Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPAR and PPAR Journal of Biological Chemistry 2008 283 43 29109 29118
86. Cheng L., Ding G., Qin Q., Huang Y., Lewis W., He N., Evans R. M., Schneider M. D., Brako F. A., Xiao Y., Chen Y. E., Yang Q., Cardiomyocyte- restricted peroxisome proliferator-activated receptor- deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy Nature Medicine 2004 10 11 1245 1250
87. Ding G., Cheng L., Qin Q., Frontin S., Yang Q., PPAR modulates lipopolysaccharide-induced TNF inflammation signaling in cultured cardiomyocytes Journal of Molecular and Cellular Cardiology 2006 40 6 821 828
88. Libby P., Ridker P. M., Hansson G. K., Leducq Transatlantic Network on Atherothrombosis, Inflammation in atherosclerosis: from pathophysiology to practice Journal of Molecular and Cellular Cardiology 2009 54 23 2129 2138
89. Oliver W. R. Jr., Shenk J. L., Snaith M. R., Russell C. S., Plunket K. D., Bodkin N. L., Lewis M. C., Winegar D. A., Sznaidman M. L., Lambert M. H., Xu H. E., Sternbach D. D., Kliewer S. A., Hansen B. C., Willson T. M., A selective peroxisome proliferator-activated receptor agonist promotes reverse cholesterol transport Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5306 5311
90. Leibowitz M. D., Fivet C., Hennuyer N., Peinado-Onsurbe J., Duez H., Berger J., Cullinan C. A., Sparrow C. P., Baffic J., Berger G. D., Santini C., Marquis R. W., Tolman R. L., Smith R. G., Moller D. E., Auwerx J., Activation of PPAR alters lipid metabolism in db/db mice FEBS Letters 2000 473 3 333 336
91. Van Der Veen J. N., Kruit J. K., Havinga R., Baller J. F. W., Chimini G., Lestavel S., Staels B., Groot P. H. E., Groen A. K., Kuipers F., Reduced cholesterol absorption upon PPAR activation coincides with decreased intestinal expression of NPC1L1 Journal of Lipid Research 2005 46 3 526 534
92. Wallace J. M., Schwarz M., Coward P., Houze J., Sawyer J. K., Kelley K. L., Chai A., Rudel L. L., Effects of peroxisome proliferator-activated receptor / agonists on HDL-cholesterol in vervet monkeys Journal of Lipid Research 2005 46 5 1009 1016
93. Rosenson R. S., Otvos J. D., Freedman D. S., Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial American Journal of Cardiology 2002 90 2 89 94
94. Akiyama T. E., Lambert G., Nicol C. J., Matsusue K., Peters J. M., Brewer H. B. Jr., Gonzalez F. J., Peroxisome proliferator-activated receptor / regulates very low density lipoprotein production and catabolism in mice on a Western diet Journal of Biological Chemistry 2004 279 20 20874 20881
95. Tanaka T., Yamamoto J., Iwasaki S., Asaba H., Hamura H., Ikeda Y., Watanabe M., Magoori K., Ioka R. X., Tachibana K., Watanabe Y., Uchiyama Y., Sumi K., Iguchi H., Ito S., Doi T., Hamakubo T., Naito M., Auwerx J., Yanagisawa M., Kodama T., Sakai J., Activation of peroxisome proliferator-activated receptor induces fatty acid -oxidation in skeletal muscle and attenuates metabolic syndrome Proceedings of the National Academy of Sciences of the United States of America 2003 100 26 15924 15929
96. Skogsberg J., Kannisto K., Cassel T. N., Hamsten A., Eriksson P., Ehrenborg E., Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 4 637 643
97. Gouni-Berthold I., Giannakidou E., Faust M., Berthold H. K., Krone W., The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls Atherosclerosis 2005 183 2 336 341
98. Robitaille J., Gaudet D., Prusse L., Vohl M.-C., Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta -87TC polymorphism and dietary fat in French-Canadians International Journal of Obesity 2007 31 3 411 417
99. Tan N. S., Michalik L., Desvergne B., Wahli W., Peroxisome proliferator-activated receptor- as a target for wound healing drugs Expert Opinion on Therapeutic Targets 2004 8 1 39 48
100. Oliver W. R. Jr., Shenk J. L., Snaith M. R., Russell C. S., Plunket K. D., Bodkin N. L., Lewis M. C., Winegar D. A., Sznaidman M. L., Lambert M. H., Xu H. E., Sternbach D. D., Kliewer S. A., Hansen B. C., Willson T. M., A selective peroxisome proliferator-activated receptor agonist promotes reverse cholesterol transport Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5306 5311
101. Vosper H., Patel L., Graham T. L., Khoudoli G. A., Hill A., Macphee C. H., Pinto I., Smith S. A., Suckling K. E., Wolf C. R., Palmer C. N. A., The peroxisome proliferator-activated receptor promotes lipid accumulation in human macrophages Journal of Biological Chemistry 2001 276 47 44258 44265
102. Lee C.-H., Chawla A., Urbiztondo N., Liao D., Boisvert W. A., Evans R. M., Transcriptional repression of atherogenic inflammation: modulation by PPAR Science 2003 302 5644 453 457
103. Li A. C., Binder C. J., Gutierrez A., Brown K. K., Plotkin C. R., Pattison J. W., Valledor A. F., Davis R. A., Willson T. M., Witztum J. L., Palinski W., Glass C. K., Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPAR, /, and Journal of Clinical Investigation 2004 114 11 1564 1576
104. Libby P., Inflammation in atherosclerosis Nature 2002 420 6917 868 874
105. Welch J. S., Ricote M., Akiyama T. E., Gonzalez F. J., Glass C. K., PPAR and PPAR negatively regulate specific subsets of lipopolysaccharide and IFN- target genes in macrophages Proceedings of the National Academy of Sciences of the United States of America 2003 100 11 6712 6717
106. Graham T. L., Mookherjee C., Suckling K. E., Palmer C. N. A., Patel L., The PPAR agonist GW0742X reduces atherosclerosis in LDLR -/- mice Atherosclerosis 2005 181 1 29 37
107. Reed K. R., Sansom O. J., Hayes A. J., Gescher A. J., Winton D. J., Peters J. M., Clarke A. R., PPAR status and Apc-mediated tumourigenesis in the mouse intestine Oncogene 2004 23 55 8992 8996
108. Harman F. S., Nicol C. J., Marin H. E., Ward J. M., Gonzalez F. J., Peters J. M., Peroxisome proliferator-activated receptor- attenuates colon carcinogenesis Nature Medicine 2004 10 5 481 483
109. Gupta R. A., Wang D., Katkuri S., Wang H., Dey S. K., DuBois R. N., Activation of nuclear hormone receptor peroxisome proliferator-activated receptor- accelerates intestinal adenoma growth Nature Medicine 2004 10 3 245 247 (Pubitemid 38667613)
110. Park B. H., Vogelstein B., Kinzler K. W., Genetic disruption of PPAR decreases the tumorigenicity of human colon cancer cells Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2598 2603
111. Saez E., Tontonoz P., Nelson M. C., Alvarez J. G. A., Ming U T., Baird S. M., Thomazy V. A., Evans R. M., Activators of the nuclear receptor PPAR enhance colon polyp formation Nature Medicine 1998 4 9 1058 1061
112. Lefebvre A.-M., Chen I., Desreumaux P., Najib J., Fruchart J.-C., Geboes K., Briggs M., Heyman R., Auwerx J., Activation of the peroxisome proliferator-activated receptor promotes the development of colon tumors in C57BL/6J-APC Min /+ mice Nature Medicine 1998 4 9 1053 1057